aberrations.112 Lastly, the alternative BTK inhibitor acalabrutinib was not too long ago authorized via the FDA (not through the EMA but) as frontline therapy in perspective of the outcome of a section III demo comparing acalabrutinib versus????? ?? ?? ? ??? ????????????? ????????????????? ???????????????????Tentu sangat banyak sekali mulai dari bo